{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:58:31Z","timestamp":1773010711946,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jpeds.2017.08.076","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T22:17:08Z","timestamp":1511302628000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease"],"prefix":"10.1016","volume":"191","author":[{"given":"Takasuke","family":"Ebato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-5987","authenticated-orcid":false,"given":"Yoshihito","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-2341","authenticated-orcid":false,"given":"Masahiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.08.076_bib0010","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0015","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial","volume":"129","author":"Ogata","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0020","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-008-0727-9","article-title":"Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease","volume":"168","author":"Okada","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/INF.0b013e318220c3cf","article-title":"Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin","volume":"30","author":"Suzuki","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0045","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/CIRCULATIONAHA.111.028423","article-title":"Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective atudy","volume":"124","author":"Kanai","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0055","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsivenesss in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment","volume":"166","author":"Sano","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0065","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0070","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1253\/circj.CJ-66-0096","article-title":"Guidelines for diagnosis and management of cardiovascular sequel in Kawasaki disease (JCS 2013). Digest version","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1203\/PDR.0b013e3181baa3c2","article-title":"Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone","volume":"66","author":"Ogata","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jpeds.2006.05.025","article-title":"A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome","volume":"149","author":"Inoue","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0085","series-title":"The adrenocortical steroids. Review of medical pharmacology","first-page":"353","author":"Meyers","year":"1980"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM197602262940905","article-title":"Nonassociation of adrenocorticosteroid therapy and peptic ulcer","volume":"294","author":"Conn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/pr.2014.92","article-title":"Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance","volume":"76","author":"Ogihara","year":"2014","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2188\/jea.JE20110126","article-title":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey","volume":"22","author":"Nakamura","year":"2012","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0105","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heart.83.3.307","article-title":"Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function","volume":"83","author":"Iemura","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jpeds.2017.08.076_bib0115","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(98)00033-3","article-title":"Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine","volume":"31","author":"Yamakawa","year":"1998","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617311575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617311575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T18:54:16Z","timestamp":1535223256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617311575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":22,"alternative-id":["S0022347617311575"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.076","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}